Assignee
EISENBACH-SCHWARTZ MICHAL
IL·4 granted patents·7 pending applications·7 citations·filing 2004–2011
Top patents by PatentIndex Score
11 records- 0176US8716228B2GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalitiesEISENBACH-SCHWARTZ MICHAL·Filed 2010·Granted May 6, 2014·4 cites·13 claims
- 0272US8828404B2Vaccine and method for treatment of neurodegenerative diseasesEISENBACH-SCHWARTZ MICHAL·Filed 2011·Granted Sep 9, 2014·2 cites·17 claims
- 0366US8895501B2Eye-drop vaccine containing copolymer 1 for therapeutic immunizationEISENBACH-SCHWARTZ MICHAL·Filed 2009·Granted Nov 25, 2014·1 cites·14 claims
- 0458US2007225251A1Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal DegenerationEISENBACH-SCHWARTZ MICHAL·Filed 2004·Application pending·0 cites
- 0552US2008085269A1Vaccine And Method For Treatment Of Neurodegenerative DiseasesEISENBACH-SCHWARTZ MICHAL·Filed 2004·Application pending·0 cites
- 0652US2011117115A1Method and vaccine comprising copolymer 1 for treatment of psychiatric disordersEISENBACH-SCHWARTZ MICHAL·Filed 2004·Application pending·0 cites
- 0752US2013230499A1Cellular blood markers for early diagnosis of als and for als progressionEISENBACH-SCHWARTZ MICHAL·Filed 2011·Application pending·0 cites
- 0848US2009191173A1Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1EISENBACH-SCHWARTZ MICHAL·Filed 2005·Application pending·0 cites
- 0945US9089509B2Method of treatment of age-related macular degenerationEISENBACH-SCHWARTZ MICHAL·Filed 2007·Granted Jul 28, 2015·0 cites·4 claims
- 1044US2012135016A1Induction of neurogenesis and stem cell therapy in combination with copolymer 1EISENBACH-SCHWARTZ MICHAL·Filed 2011·Application pending·0 cites
- 1143US2007248569A1Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic ImmunizationEISENBACH-SCHWARTZ MICHAL·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EISENBACH-SCHWARTZ MICHAL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →